Status:
WITHDRAWN
CT Biomarkers Identification by Artificial Intelligence for COVID-19 Prognosis
Lead Sponsor:
Centre Hospitalier Universitaire de Nīmes
Conditions:
Covid-19
Eligibility:
All Genders
Brief Summary
The study hypothesis is that low-dose computed tomography (LDCT) coupled with artificial intelligence by deep learning would generate imaging biomarkers linked to the patient's short- and medium-term ...
Eligibility Criteria
Inclusion
- Patients positive for SARS-CoV-2 according to RT-PCR test between 1st March and 31st May 2020
- Patients undergoing low dose CT scan to establish Covid-19 lung damage
- Available for at least 8 days follow-up
Exclusion
- • Patients opposing the retrospective use of their data
Key Trial Info
Start Date :
March 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2021
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04418245
Start Date
March 1 2020
End Date
September 1 2021
Last Update
March 10 2025
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU la Timone
Marseille, France
2
CHU Montpellier
Montpellier, France
3
CHU de Nimes
Nîmes, France
4
CHU Poitiers
Poitiers, France